Wild-derived mouse strains, a valuable model to study B cell responses

Molecular Immunology

Volumn 46, Issue 4, 2009, Pages 601-612

  Thiriot, Aude ^a   Drapier, Anne Marie ^a   Mémet, Sylvie ^a   Fitting, Catherine ^a   Sturny Leclere, Aude ^a   Cavaillon, Jean Marc ^a   Cazenave, Pierre André ^a   Freitas, Antonio A ^a   Rueff Juy, Dominique ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

B cells; Macrophages; TLR deficiency; Wild derived mouse strains

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD40 LIGAND MONOCLONAL ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; LIGANDS; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MODELS, ANIMAL; OLIGODEOXYRIBONUCLEOTIDES; POLYMORPHISM, GENETIC; PROTEIN KINASES; TOLL-LIKE RECEPTORS;

MUS;

EID: 58249116681     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.07.027     Document Type: Article

References (47)

1. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2 (2001) 675-680
2. Andrew S.M., and Titus J.A. Fragmentation of immunoglobulin G. In: Coligan J.E., Bierer B.E., Margulies D.H., Shevach E.M., and Strober W. (Eds). Current Protocols in Immunology vol. 1 (2001), Wiley J. and Sons, Inc., New York 2.8.1-2.8.10
3. Babay B.E., Louzir H., Kebaier C., Boubaker S., Dellagi K., and Cazenave P.A. Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major. Infect. Immun. 72 (2004) 4603-4611
4. Bagot S., Campino S., Penha-Goncalves C., Pied S., Cazenave P.A., and Holmberg D. Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 9919-9923 (Epub 2002 July 11)
5. Barton G.M., and Medzhitov R. Toll-like receptor signaling pathways. Science 300 (2003) 1524-1525
6. Bernasconi N.L., Onai N., and Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101 (2003) 4500-4504
7. Cariappa A., Liou H.C., Horwitz B.H., and Pillai S. Nuclear factor kappa B is required for the development of marginal zone B lymphocytes. J. Exp. Med. 192 (2000) 1175-1182
8. Caroff M., Karibian D., Cavaillon J.M., and Haeffner-Cavaillon N. Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect. 4 (2002) 915-926
9. Claflin L.J., Lieberman R., and Davie J.M. Clonal nature of immune response to phosphorylcholine. I. Specificity, class and idiotope of phosphorylcholine-binding receptors on lymphoid cells. J. Exp. Med. 139 (1974) 58-68
10. Conner J.R., Smirnova I.I., and Poltorak A. Forward genetic analysis of Toll-like receptor responses in wild-derived mice reveals a novel antiinflammatory role for IRAK1BP1. J. Exp. Med. 205 (2008) 305-314
11. Coutinho A., Gronowicz E., Bullock W.W., and Moller G. Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J. Exp. Med. 139 (1974) 74-92
12. Czerkinsky C.C., Nilsson L.A., Nygren H., Ouchterlony O., and Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65 (1983) 109-121
13. Dong S., Corre B., Foulon E., Dufour E., Veillette A., Acuto O., and Michel F. T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2. J. Exp. Med. 203 (2006) 2509-2518
14. Feuillard J., Memet S., Goudeau B., Lilienbaum A., Schmidt-Ullrich R., Raphael M., and Israel A. In vivo identification of lymphocyte subsets exhibiting transcriptionally active NF-kappaB/Rel complexes. Int. Immunol. 12 (2000) 613-621
15. Genestier L., Taillardet M., Mondiere P., Gheit H., Bella C., and Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J. Immunol. 178 (2007) 7779-7786
16. Harnett M.M. CD40: a growing cytoplasmic tale. Sci. STKE 2004 (2004) pe25
17. Hayashi E.A., Akira S., and Nobrega A. Role of TLR in B cell development: signaling through TLR4 promotes B cell maturation and is inhibited by TLR2. J. Immunol. 174 (2005) 6639-6647
18. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
19. Kawai T., and Akira S. TLR signaling. Cell Death Differ. 13 (2006) 816-825
20. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
21. Lernbecher T., Kistler B., and Wirth T. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J. 13 (1994) 4060-4069
22. Lyons A.B., and Parish C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171 (1994) 131-137
23. Mahieu T., Park J.M., Revets H., Pasche B., Lengeling A., Staelens J., Wullaert A., Vanlaere I., Hochepied T., van Roy F., Karin M., and Libert C. The wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN-{beta} production. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 2292-2297
24. Medzhitov, R., Barton, G.M., 2008. Toll-like receptor pathway. Sci. STKE (Connections Map in the Database of Cell Signaling, as seen 7 June 2008), http://stke.sciencemag.org/cgi/cm/stkecm; CMP_8643.
25. Medzhitov R., and Janeway Jr. C. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173 (2000) 89-97
26. Meyer-Bahlburg A., Khim S., and Rawlings D.J. B cell intrinsic TLR signals amplify but are not required for humoral immunity. J. Exp. Med. 204 (2007) 3095-3101
27. Mizuno T., and Rothstein T.L. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B. J. Immunol. 170 (2003) 2806-2810
28. Mizuno T., and Rothstein T.L. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma. J. Immunol. 174 (2005) 6062-6070
29. Nagai Y., Shimazu R., Ogata H., Akashi S., Sudo K., Yamasaki H., Hayashi S., Iwakura Y., Kimoto M., and Miyake K. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99 (2002) 1699-1705
30. Pasare C., and Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 438 (2005) 364-368
31. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
32. Richards J.D., Dave S.H., Chou C.H., Mamchak A.A., and DeFranco A.L. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen. J. Immunol. 166 (2001) 3855-3864
33. Sato S., Nomura F., Kawai T., Takeuchi O., Muhlradt P.F., Takeda K., and Akira S. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J. Immunol. 165 (2000) 7096-7101
34. Schmidt-Ullrich R., Memet S., Lilienbaum A., Feuillard J., Raphael M., and Israel A. NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. Development 122 (1996) 2117-2128
35. Silver K., Ferry H., Crockford T., and Cornall R.J. TLR4, TLR9 and MyD88 are not required for the positive selection of autoreactive B cells into the primary repertoire. Eur. J. Immunol. 36 (2006) 1404-1412
36. Smirnova I., Poltorak A., Chan E.K., McBride C., and Beutler B. Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol. 1 (2000) (RESEARCH002)
37. Stephan K., Smirnova I., Jacque B., and Poltorak A. Genetic analysis of the innate immune responses in wild-derived inbred strains of mice. Eur. J. Immunol. 37 (2007) 212-223
38. Tahri-Jouti M.A., Mondange M., Le Dur A., Auzanneau F.I., Charon D., Girard R., and Chaby R. Specific binding of lipopolysaccharides to mouse macrophages-II. Involvement of distinct lipid a substructures. Mol. Immunol. 27 (1990) 763-770
39. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376 (Epub 2001 December 19)
40. Thiriot A., Drapier A.M., Vieira P., Fitting C., Cavaillon J.M., Cazenave P.A., and Rueff-Juy D. The Bw cells, a novel B cell population conserved in the whole genus Mus. J. Immunol. 179 (2007) 6568-6578
41. Turcotte K., Loredo-Osti J.C., Fortin P., Schurr E., Morgan K., and Gros P. Complex genetic control of susceptibility to Mycobacterium bovis (Bacille Calmette-Guerin) infection in wild-derived Mus spretus mice. Genes Immun. 7 (2006) 684-687
42. Valitutti S., Muller S., Cella M., Padovan E., and Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375 (1995) 148-151
43. Vollmer J., Weeratna R., Payette P., Jurk M., Schetter C., Laucht M., Wader T., Tluk S., Liu M., Davis H.L., and Krieg A.M. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 34 (2004) 251-262
44. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol. 25 (2004) 381-386
45. Yi A.K., Yoon J.G., Hong S.C., Redford T.W., and Krieg A.M. Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-alpha production through activation of NF-kappaB. Int. Immunol. 13 (2001) 1391-1404
46. Yi A.K., Yoon J.G., and Krieg A.M. Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-kappaB activation pathways: regulation by mitogen-activated protein kinases. Int. Immunol. 15 (2003) 577-591
47. Zhang H., Peterson J.W., Niesel D.W., and Klimpel G.R. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J. Immunol. 159 (1997) 4868-4878